We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-43.14%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$100M
AUM Growth
-$36.6M
Cap. Flow
-$10.6M
Cap. Flow %
-10.62%
Top 10 Hldgs %
93.38%
Holding
105
New
21
Increased
12
Reduced
17
Closed
48

Top Buys

Rank Stock Value
1
AIRE icon
reAlpha
AIRE
+$3.43M
2
FMTO
Femto Technologies Inc. Common Stock
FMTO
+$2.56M
3
GGE
Green Giant Inc. Common Stock
GGE
+$2.37M
4
MMAT
Meta Materials Inc. Common Stock
MMAT
+$1.64M
5
PHUN icon
Phunware
PHUN
+$1.41M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$12.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.67M
3
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$2.17M
4
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$817K
5
AIOS
AIOS Tech
AIOS
+$528K

Sector Composition

Rank Sector Weight
1 Technology 4.2%
2 Healthcare 3.82%
3 Energy 0.81%
4 Real Estate 0.76%
5 Materials 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANY icon
26
CALL
Sphere 3D
ANY
$16.8M
$186K 0.19%
57
– –
BJDX icon
27
Bluejay Diagnostics
BJDX
$1.03M
$183K 0.18%
94
+81
+623% +$439K
PMCB icon
28
PharmaCyte Biotech
PMCB
$6.33M
$178K 0.18%
82,373
-14,751
-15% -$32K
GGE
29
DELISTED
Green Giant Inc. Common Stock
GGE
$171K 0.17%
+3,267,444
New +$2.37M
MAIA icon
30
MAIA Biotechnology
MAIA
$75.4M
$153K 0.15%
+130,510
New +$211K
BTCT icon
31
BTC Digital
BTCT
$8.46M
$140K 0.14%
+29,073
New +$105K
SCNI
32
Scinai Immunotherapeutics
SCNI
$1.36M
$131K 0.13%
22,066
-2,431
-10% -$16.7K
PHIO icon
33
Phio Pharmaceuticals
PHIO
$11.7M
$131K 0.13%
19,188
+1,850
+11% +$19K
GCTK icon
34
GlucoTrack
GCTK
$1.97M
$112K 0.11%
71
-263
-79% -$349K
NEPT
35
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$104K 0.1%
194,606
+7,716
+4% +$5.69K
PULM icon
36
Pulmatrix
PULM
$6.14M
$101K 0.1%
54,188
-97,162
-64% -$186K
AUMN
37
DELISTED
Golden Minerals Company
AUMN
$98.8K 0.1%
+190,022
New +$135K
APVO icon
38
Aptevo Therapeutics
APVO
$5.25M
$63.3K 0.06%
1
-1
-50% -$142K
AMPGW
39
DELISTED
Amplitech Group Warrants
AMPGW
$56.6K 0.06%
410,220
-5,649
-1% -$951
RIBT
40
DELISTED
RiceBran Technologies
RIBT
$52.5K 0.05%
+225,850
New +$86.2K
WLDSW icon
41
Wearable Devices Ltd Warrant
WLDSW
$135K
$47.5K 0.05%
943
+9
+1% +$502
EFTR
42
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$46.7K 0.05%
+4,000
New +$53.6K
GWAV icon
43
Greenwave Technology Solutions
GWAV
$2.06M
$39.3K 0.04%
4
+2
+100% +$17.7K
NCRA icon
44
Nocera
NCRA
$2.23M
$37.7K 0.04%
951
– –
IFBD icon
45
Infobird
IFBD
$9.09M
$26.2K 0.03%
2,500
-628
-20% -$9.1K
IVF
46
INVO Fertility Inc
IVF
$1.75M
$25.1K 0.03%
13
-147
-92% -$274K
GMBLZ
47
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$23K 0.02%
4,590,196
-39,333
-0.8% -$169
CINGW icon
48
Cingulate Inc Warrants
CINGW
$59.3K
$16.8K 0.02%
559,216
-6,553
-1% -$436
TBLT
49
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$16.7K 0.02%
1,630
-21,775
-93% -$249K
SXTPW icon
50
60 Degrees Pharmaceuticals Warrant
SXTPW
$12.3K 0.01%
306,717
– –
1
2
3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q4 2023 Portfolio in Review

As of Q4 2023, Sabby Management held 105 positions worth $100M, down 27% from $137M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Sabby Management withdrew a net $10.6M in Q4 2023, closing 48 positions and reducing 17 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, up from 0.43% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Sabby Management opened a new position in reAlpha worth $370K.

  • Sabby Management's largest Q4 2023 buy was reAlpha: 7,430 shares worth $370K.
  • Sabby Management added most to Tonix Pharmaceuticals in Q4 2023, an estimated $929K increase.
  • Sabby Management's biggest Q4 2023 reduction was GlucoTrack, cutting an estimated $349K.
  • Sabby Management fully exited iShares Russell 2000 ETF in Q4 2023, selling an estimated $12.9M.
  • Sabby Management's ten largest holdings make up 93% of its $100M portfolio in Q4 2023.
  • Sabby Management opened 21 new positions and closed 48 in Q4 2023.
  • Sabby Management's portfolio value fell 27% quarter-over-quarter to $100M.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.